A 2022 review of 76 clinical trials noted participants who used GLP-1s specifically for weight loss, took a higher dose, and/or used the medication for more than 26 weeks were at a higher risk for gallbladder issues
The most commonly reported side effects are gastrointestinal nausea, constipation, diarrhea, and reduced appetite and are often most noticeable when starting or increasing a dose
Results will provide the first controlled data on this approach
Reducing the amount of sugar your liver makes
Related animal studies have further affirmed that Liraglutide can effectively suppress liver cancer progression in mouse models of diabetes and nonalcoholic steatohepatitis (NASH) [44]
[DOI] [PubMed] [Google Scholar] 6.Kendall DM, Riddle MC, Rosenstock J, Zhuang D, Kim DD, Fineman MS, Baron AD